Study Identifies DNA Polymerase Kappa's Role in Cisplatin Resistance in Cancer Cells
Researchers have independently identified molecular pathways that cancer cells exploit to resist DNA-damaging therapies, including cisplatin and PARP inhibitors. One study found that DNA polymerase Kappa (Pol κ) stabilizes stalled replication forks in head and neck cancer cells, while a second identified a small molecule, UNI418, that dismantles cancer cells' DNA repair machinery to restore drug sensitivity. Both findings point to protein stability and replication fork protection as critical vulnerabilities in treatment-resistant cancers.
Two independent research efforts have shed new light on how cancer cells evade DNA-damaging treatments. The first study, using head and neck squamous carcinoma cells (HNSCC), found that DNA polymerase Kappa (Pol κ) forms two key molecular axes — one with PCNA and Pol δ to support cell proliferation, and another with PCNA and the deubiquitinase USP18 — that together stabilize stalled replication forks and protect critical DNA repair proteins from degradation under cisplatin-induced stress. Notably, Pol κ's catalytic activity appears less important than its structural role in rewiring the replication fork. The second study, published in Nature Communications by researchers at the Institute for Basic Science in South Korea, identified a small molecule called UNI418 that activates the Cul4A ubiquitin ligase complex by reducing levels of IP6, a metabolite that normally restrains this protein-degradation pathway. This causes the rapid breakdown of key homologous recombination proteins such as RAD51 and CHK1, effectively disabling DNA repair even in cancers that had previously regained resistance to PARP inhibitors. In animal models, UNI418 combined with the PARP inhibitor Olaparib slowed tumor growth, including in treatment-resistant models, suggesting a viable combination therapy strategy. Together, the studies highlight protein homeostasis and replication fork stability as central battlegrounds in cancer drug resistance.
What's missing
Both studies are at early stages — the HNSCC/Pol κ work is a preprint on bioRxiv and has not yet undergone peer review, while the UNI418 study, though published in Nature Communications, has only been tested in cell lines and xenograft models. Neither study reports clinical trial data, pharmacokinetic profiles, or safety assessments in humans, which are necessary steps before therapeutic application. The Pol κ study does not specify whether Pol κ inhibitors currently exist or are in development. The UNI418 study does not address potential off-target effects of broadly disrupting IP6 signaling or protein degradation pathways in normal cells.
What different sources said
- Science DailyCenter
Scientists shut down cancer DNA repair to overcome drug resistance
- bioRxivCenter
PCNA-Pol κ-Polδ /USP18 axes stabilize replication fork and restart to reduce cisplatin cytotoxicity
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.